Marcello Damiani
Direktor/Vorstandsmitglied bei Cellarity Inc.
Ursprung des Netzwerks ersten Grades von Marcello Damiani
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 47 | |
21
| Public Company | Medical Specialties | 21 |
12
| Public Company | Biotechnology | 12 |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA.
12
| Holding Company | Biotechnology | 12 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.
7
| Subsidiary | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marcello Damiani
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Chief Executive Officer Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor Private Equity Investor Private Equity Analyst | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Human Resources Officer | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Chairman | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Director/Board Member Founder Founder | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Founder | |
| QIAGEN N.V. | Medical Specialties | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Founder Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | President Public Communications Contact Corporate Officer/Principal | |
bioMERIEUX Benelux SANV
 bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Boston University | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member Consultant / Advisor Consultant / Advisor | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Founder | |
| BG MEDICINE, INC. | Medical Specialties | Founder Chairman President | |
| ONCORUS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Packaged Software | Chairman Chief Executive Officer Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | Founder Founder | |
| Dartmouth College | College/University | Masters Business Admin Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer | |
YourBio Health, Inc.
 YourBio Health, Inc. Electronic Equipment/InstrumentsElectronic Technology YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Pharmaceuticals: Other | Chairman Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Corporate Officer/Principal | |
Google LLC
 Google LLC Internet Software/ServicesTechnology Services Google LLC engages in the operation of internet portal and search index website. It provides online advertising technologies, search engine, cloud computing, and software solutions. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on September 4, 1998 and is headquartered in Mountain View, CA. | Internet Software/Services | Corporate Officer/Principal Corporate Officer/Principal | |
Qiagen SRL
 Qiagen SRL Medical SpecialtiesHealth Technology Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
Compagnie Merieux Alliance SAS
 Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Chief Tech/Sci/R&D Officer |
Statistik
International
| Vereinigte Staaten | 39 |
| Frankreich | 4 |
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 466 |
| Corporate Officer/Principal | 219 |
| Independent Dir/Board Member | 126 |
| Founder | 78 |
| Chairman | 63 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Peter Hutt | 69 |
| Paul Sagan | 38 |
| Elizabeth Nabel | 31 |
| Elizabeth Tallett | 28 |
| Francois Nader | 28 |
| Theo Melas-Kyriazi | 26 |
| Harold Y. H. Boël | 26 |
| James Collins | 25 |
| Agnès Lemarchand | 25 |
| David Meline | 24 |
| Stéphane Bancel | 23 |
| Olivier Brandicourt | 23 |
| Moncef Slaoui | 22 |
| Marie-Hélène Habert-Dassault | 22 |
- Börse
- Insiders
- Marcello Damiani
- Unternehmensverbindungen
